Background illustration for clinical trials search

Paid Clinical Trials Bronx

Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype,
Location: New York NY, Chicago IL, Dallas TX, Houston TX,
Sponsor: Debiopharm International SA

Sex: All

Age: 18+

Code: NCT05765812

Phase 1, Phase 2, Recruiting

Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)

for
Graft-versus-host Disease
Location: New Hyde Park NY
Sponsor: Northwell Health

Sex: All

Age: 14 - 70+

Code: NCT05289167

Phase 1, Phase 2, Recruiting

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

for
Ovarian Neoplasms, Endometrial Neoplasms,
Location: New York NY, Mineola NY, Columbus OH, Grand Rapids MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06400472

Phase 1, Recruiting

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

for
Schizophrenia
Location: Cedarhurst NY, Staten Island NY, Kalamazoo MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 55

Code: NCT07615426

Phase 1, Recruiting

NYU Epilepsy Self-Management Study

for
Epilepsy
Location: New York NY, Brooklyn NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT07087821

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

for
Multiple Myeloma
Location: New York NY, Harrison NY, Uniondale NY, Montvale NJ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05623020

Phase 3, Recruiting

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

for
Venous Thromboembolism (VTE)
Location: New York NY
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07493304

Phase 3, Recruiting

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

for
Solid Tumors, Sarcoma
Location: New York NY, Boston MA, Nashville TN
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644755

Phase 1, Recruiting

PlayReadVIP in Family Child Care

for
Caregiver-Child Interaction, Child Learning
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT07489079

Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer,
Location: New York NY, Boston MA, Washington D.C. DC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06586515

Phase 1, Recruiting

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Location: New York NY, Jacksonville FL, Coon Rapids MN, Mobile AL
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07218341

Recruiting
New

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

for
Hormone Receptor Positive, HER2-low or HER2-ultralow,
Location: New York NY
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07701941

Phase 1, Phase 2, Recruiting

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

for
Gout
Location: Hartsdale NY, Brooklyn NY, Sparta NJ, Rockville MD,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07535034

Phase 2, Recruiting

Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema

for
Phlebolymphedema, Lymphedema, Chronic Venous Insufficiency
Location: New York NY
Sponsor: Koya Medical, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06418282

Recruiting

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

for
Acute Stroke, Ischemic Stroke, Stroke
Location: New York NY, Philadelphia PA, Worcester MA, North York,
Sponsor: DiaMedica Therapeutics Inc

Sex: All

Age: 18 - 70+

Code: NCT05065216

Phase 2, Phase 3, Recruiting

MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

for
Prostate Disease, Elevated Prostate Specific Antigen,
Location: New York NY, Lake Success NY
Sponsor: Ardeshir Rastinehad

Sex: Male

Age: 18+

Code: NCT04599218

Recruiting

Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL

for
Anaplastic Large Cell Lymphoma, ALK-Positive
Location: Valhalla NY
Sponsor: New York Medical College

Sex: All

Age: 1 - 39

Code: NCT07013565

Phase 2, Recruiting

Preventing Tipping Points in High Comorbidity Patients: A Lifeline From Health Coaches

for
Comorbidity, Self-Management
Location: New York NY, Brooklyn NY, Chicago IL
Sponsor: Clinical Directors Network

Sex: All

Age: 18+

Code: NCT04176510

Recruiting

A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

for
Gastric Cancer, Gastroesophageal-junction Cancer
Location: New York NY, Harrison NY, Uniondale NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07631000

Phase 2, Recruiting

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic,
Location: New York NY, Camp Hill PA, Pasadena MD, Sherbrooke,
Sponsor: Apollo Therapeutics Ltd

Sex: All

Age: 18 - 65

Code: NCT07599813

Phase 2, Recruiting